Search

everythinglearnresearchcommunity

for

Search:↓

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Ulcerative colitis can cause skin issues due to immune system problems.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

TNF-alpha inhibitors can cause various immune-related skin issues.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

New cytokine-targeted therapies show promise for treating alopecia areata.